Circulation Research, Vol 63, 306-312, Copyright © 1988 by American Heart Association
ARTICLES |
U Forstermann, A Mugge, SM Bode and JC Frolich
Department of Clinical Pharmacology, Hannover Medical School, FRG.
Epicardial human coronary arteries (HCA) were obtained during heart transplantation. Strip preparations were mounted for isometric tension recording. Tension was induced with prostaglandin F2 alpha (0.3-3 microM). Aggregating human platelets (10(7)/ml and 10(8)/ml) caused marked relaxation if the endothelium of the HCA was intact, but produced modest additional constriction if the endothelium was removed. The endothelium-dependent relaxations to platelets were slightly enhanced in the presence of methysergide (1 microM) or after treatment of the platelets with the thromboxane synthase inhibitor dazmegrel (1 mM, 30 minutes). Relaxations to platelets were markedly inhibited or abolished in the presence of apyrase (1 unit/ml), after selective pretreatment of HCA with gossypol or methylene blue (both 30 microM, 30 minutes), or after addition of hemoglobin (20 microM) to the organ bath. Pretreatment of HCA (not the platelets) with aspirin (30 microM, 30 minutes) had no significant effect on platelet-induced relaxations. Adenosine 5'-diphosphate (0.1-100 microM) induced marked relaxations in endothelium-intact and much smaller relaxations in endothelium-denuded HCA. A low concentration (10 nM) of serotonin (5-HT) produced modest endothelium-dependent relaxations, higher concentrations (0.1-1 microM) led to increases in tension (also in the presence of endothelium). The thromboxane A2 mimetic U44069 (1-100 nM) was the most potent constrictor of HCA irrespective of the presence or absence of endothelium. After inhibition of thromboxane synthase, platelets produced large amounts of prostaglandins E2 and F2 alpha. Both prostaglandins constricted HCA, which can explain the limited effects of dazmegrel.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
L. A. Holowatz, J. D. Jennings, J. A. Lang, and W. L. Kenney Ketorolac alters blood flow during normothermia but not during hyperthermia in middle-aged human skin J Appl Physiol, October 1, 2009; 107(4): 1121 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Holowatz and W. L. Kenney Chronic low-dose aspirin therapy attenuates reflex cutaneous vasodilation in middle-aged humans J Appl Physiol, February 1, 2009; 106(2): 500 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rousseau, M. Tartas, B. Fromy, A. Godon, M.-A. Custaud, J. L. Saumet, and P. Abraham Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1420 - R1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tartas, P. Bouye, A. Koitka, V. Jaquinandi, L. Tan, J. L. Saumet, and P. Abraham Cathodal current-induced vasodilation to single application and the amplified response to repeated application in humans rely on aspirin-sensitive mechanisms J Appl Physiol, October 1, 2005; 99(4): 1538 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawano, H. Tsuji, H. Nishimura, S. Kimura, S. Yano, N. Ukimura, Y. Kunieda, M. Yoshizumi, T. Sugano, K. Nakagawa, et al. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells Blood, March 15, 2001; 97(6): 1697 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kriston, R. C. Venuto, C. Baylis, and G. Losonczy Hemodynamic and renal effects of U-46619, a TXA2/PGH2 analog, in late-pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R831 - R837. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Kinn and R. J. Bache Effect of Platelet Activation on Coronary Collateral Blood Flow Circulation, October 6, 1998; 98(14): 1431 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Oskarsson, T. G. Hofmeyer, and M. T. Olivari Cyclosporine Impairs the Ability of Human Platelets to Mediate Vasodilation Hypertension, June 1, 1997; 29(6): 1314 - 1321. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |